Lv11
22 积分 2026-06-30 加入
Nonclinical Pharmacokinetics Study of OLX702A-075-16, N-Acetylgalactosamine Conjugated Asymmetric Small Interfering RNA (GalNAc-asiRNA)
5小时前
待确认
Switching off the FNIP1 gene protects against metabolic disease
20天前
已完结
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial
24天前
已完结
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials
1个月前
已完结
Fitusiran: First Approval
1个月前
已完结
2-Aminopyridines as Potent and Selective Nav1.8 Inhibitors Exhibiting Efficacy in a Nonhuman Primate Pain Model
1个月前
已完结
Clinical Implications of SCN10A Loss-of-Function Variants in 169 610 Exomes Representing the General Population
1个月前
已完结
Integrated Stress Response (ISR) Pathway: Unraveling Its Role in Cellular Senescence
1个月前
已完结
Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of N-Acetylgalactosamine–Conjugated Small Interfering RNA Disposition and Gene Silencing in Preclinical Species and Humans
1个月前
已完结
Deubiquitinating enzymes in skeletal muscle atrophy—An essential role for USP19
1个月前
已完结
皖公网安备34019202002308
